2000Zhonghua shenzangbing zazhiRequires access

Protective effects of losartan on diabetic glomerulopathy in STZ-induced diabetic rats

XU Min-hu

Open publisher page 0 citations

Abstract

Objndve To evaluate the protective effects of specific antagonists of angiotensin II receptor losartan on the kidneys of diabetic rats and study their mechanisms. Methods Changes of urinary albumin, β2-m excretion, creatinine clearance(Ccr), NO, ET level of plasma, urine and renal tissue, serum and urinary TGF-β1 concentration and mean glomerular volume were measured. Results Losartan could correct elevated urinary albumin, β2-m excretion, Ccr and mean glomerular volume. Urinary and renal tissue NO, ET concentration decreased after diabetic rats received losartan. Large doses of losartan also reduced urinary TGF-β1 level. Conclusion Losartan can protect the kidney of diabetic rats and the decrease of NO, ET, TGF-β1 concentration in renal tissue may be a mechanism for this action.

About this research paper

What this paper is about

Objndve To evaluate the protective effects of specific antagonists of angiotensin II receptor losartan on the kidneys of diabetic rats and study their mechanisms. Methods Changes of urinary albumin, β2-m excretion, creatinine clearance(Ccr), NO, ET level of plasma, urine and renal tissue, serum and urinary TGF-β1 concentration and mean glomerular volume were measured. Results Losartan could correct elevated urinary albumin, β2-m excretion, Ccr and mean glomerular volume. Urinary and renal tissue NO, ET concentration decreased after diabetic rats received losartan. Large doses of losartan also reduced urinary TGF-β1 level. Conclusion Losartan can protect the kidney of diabetic rats and the decrease of NO, ET, TGF-β1 concentration in renal tissue may be a mechanism for this action.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objndve To evaluate the protective effects of specific antagonists of angiotensin II receptor losartan on the kidneys of diabetic rats and study their mechanisms. Methods Changes of urinary albumin, β2-m excretion, creatinine clearance(Ccr), NO, ET level of plasma, urine and renal tissue, serum and urinary TGF-β1 concentration and mean glomerular volume were measured. Results Losartan could correct elevated urinary albumin, β2-m excretion, Ccr and mean glomerular volume. Urinary and renal tissue NO, ET concentration decreased after diabetic rats received losartan. Large doses of losartan also reduced urinary TGF-β1 level. Conclusion Losartan can protect the kidney of diabetic rats and the decrease of NO, ET, TGF-β1 concentration in renal tissue may be a mechanism for this action.

Key concepts: Losartan, Endocrinology, Internal medicine, Urinary system, Kidney, Medicine, Creatinine, Diabetes mellitus

Related papers

Back to paper searchBrowse research topicsOriginal source
Protective effects of losartan on diabetic glomerulopathy in STZ-induced diabetic rats — Research Paper | ScholarLens